Home
  >  
Section 61
  >  
Chapter 60,304

Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide

Salfinger, M.; Kafader, F.M.

Zentralblatt für Bakteriologie Mikrobiologie und Hygiene. Series A Medical Microbiology Infectious Diseases Virology Parasitology 265(3-4): 404-407

1987

ISSN/ISBN: 0176-6724
PMID: 3118600
Accession: 060303052
Download citation:  
Text
  |  
BibTeX
  |  
RIS
One hundred and sixty clinical isolates of Mycobacterium tuberculois were tested for their sensitivity to pyrazinamide (PZA) using the conventional proportion method (Middlebrook 7H10 agar) and the results compared to the pyrazinamidase (PZase) activity of the strains. The correlation between strains susceptible to PZA and the production of PZase was 99%. None of the isolates were exclusively resistant to PZA. At present the rate of initial PZA resistance in Kanton Zurich is 0.6%.

PDF emailed within 1 workday: $29.90




Related References

The Editors 2002: Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide Journal of Medical Microbiology 51(1): 11-12
Huang, Z.-K.; Luo, Q.; Jiang, B.-X.; Li, W.-T.; Xu, X.-M.; Xiong, G.-L.; Li, J.-M. 2013: Performance of the microscopic observation drug susceptibility assay in pyrazinamide susceptibility testing for Mycobacterium tuberculosis Chinese Medical Journal 126(22): 4334-4339
Zimic, M.; Loli, S.; Gilman, R.H.; Gutierrez, A.és.; Fuentes, P.; Cotrina, M.; Kirwan, D.; Sheen, P. 2012: A new approach for pyrazinamide susceptibility testing in Mycobacterium tuberculosis Microbial Drug Resistance 18(4): 372-375
Tarrand, J.J.; Spicer, A.; Groschel, D.H.M. 1983: Radiometric pyrazinamide susceptibility testing of mycobacterium tuberculosis Abstracts of the Annual Meeting of the American Society for Microbiology 83: C226
Butler, W.R.; Kilburn, J.O. 1982: Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide Journal of Clinical Microbiology 16(6): 1106-1109
Li, H.; Zhou, L.-P.; Luo, J.; Yu, J.-P.; Yang, H.; Wei, H.-P. 2016: Rapid colorimetric pyrazinamide susceptibility testing of Mycobacterium tuberculosis International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 20(4): 462-467
Heifets, L.; Sanchez, T. 2000: New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide Journal of Clinical Microbiology 38(4): 1498-1501
Ashtekar, D.R.; Fernandes, F.; Kale, R.N.; Virde, B.S.; Khadse, B.G.; Devdhar, M.N.; Ganatra, R.D.; Shah, D.H.; Shirodkar, M.V.N.; Deshpande, V.R. 1985: Rapid indirect pyrazinamide susceptibility testing of mycobacterium tuberculosis IRCS (International Research Communications System) Medical Science 13(8): 736-737
Salfinger, M.; Reller, L.B.; Demchuk, B.; Johnson, Z.T. 1989: Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis Research in Microbiology 140(4-5): 301-309
Zhang, Y.; Permar, S.; Sun, Z. 2002: Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide Journal of Medical Microbiology 51(1): 42-49
Fredricks, B.A.; DeCoster, D.J.; Kim, Y.; Sparks, N.; Callister, S.M.; Schell, R.F. 2006: Rapid pyrazinamide susceptibility testing of Mycobacterium tuberculosis by flow cytometry Journal of Microbiological Methods 67(2): 266-272
Tarrand, J.J.; Spicer, A.D.; Gröschel, D.H. 1986: Evaluation of a radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis Antimicrobial Agents and ChemoTherapy 30(6): 852-855
Cunha, J. 2012: Pyrazinamide susceptibility testing in all isolates of the Mycobacterium tuberculosis complex - a critical analysis Revista Portuguesa de Pneumologia 18(4): 188-189
Demers, A-Marie.; Venter, A.; Friedrich, S.O.; Rojas-Ponce, G.; Mapamba, D.; Jugheli, L.; Sasamalo, M.; Almeida, D.; Dorasamy, A.; Jentsch, U.; Gibson, M.; Everitt, D.; Eisenach, K.D.; Diacon, A.H. 2016: Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System Journal of Clinical Microbiology 54(5): 1276-1281
Mok, S.; Roycroft, E.; Flanagan, P.R.; Montgomery, L.; Borroni, E.; Rogers, T.R.; Fitzgibbon, M.M. 2021: Overcoming the Challenges of Pyrazinamide Susceptibility Testing in Clinical Mycobacterium tuberculosis Isolates Antimicrobial Agents and ChemoTherapy 65(8): E0261720
Davies, A.P.; Billington, O.J.; McHugh, T.D.; Mitchison, D.A.; Gillespie, S.H. 2000: Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis Journal of Clinical Microbiology 38(10): 3686-3688
Chang, K.C.; Yew, W.W.; Zhang, Y. 2011: Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses Antimicrobial Agents and ChemoTherapy 55(10): 4499-4505
Cui, Z.; Wang, J.; Lu, J.; Huang, X.; Zheng, R.; Hu, Z. 2013: Evaluation of methods for testing the susceptibility of clinical Mycobacterium tuberculosis isolates to pyrazinamide Journal of Clinical Microbiology 51(5): 1374-1380
Pholwat, S.; Stroup, S.; Gratz, J.; Trangan, V.; Foongladda, S.; Kumburu, H.; Juma, S.P.; Kibiki, G.; Houpt, E. 2014: Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis Tuberculosis 94(1): 20-25
Hoffner, S.; Angeby, K.; Sturegård, E.; Jönsson, B.; Johansson, A.; Sellin, M.; Werngren, J. 2013: Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 17(11): 1486-1490